Keisuke Shindo

2.2k citations
35 papers · 1.8k indexed · h-index 19
Topics
HIV Research and Treatment (20 papers)HIV/AIDS drug development and treatment (16 papers)Cytomegalovirus and herpesvirus research (8 papers)

In The Last Decade

Keisuke Shindo

35 papers receiving 1.8k citations

Peers

Keisuke Shindo
Comparison fields: 5 of 74
  • Virology 1.1k
  • Molecular Biology 891
  • Infectious Diseases 641
  • Epidemiology 532
  • Immunology 459
Replace Caili Hao with:
Caili Hao United States
Linda Chelico Canada
Monsef Benkirane France
Betty Poon United States
Lily I. Wu United States
Una O’Doherty United States
Uwe Tessmer Germany
Marina Lušić Italy
Heather L. Wiegand United States
Waaqo Daddacha United States
Keisuke Shindo relative to Caili Hao United States Caili Hao's profile →
Citations per field
00.5×1.5×
Caili Hao · 1×
Citations per year

Countries citing papers authored by Keisuke Shindo

Since Specialization
Citations

This map shows the geographic impact of Keisuke Shindo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keisuke Shindo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keisuke Shindo more than expected).

Fields of papers citing papers by Keisuke Shindo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keisuke Shindo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keisuke Shindo. The network helps show where Keisuke Shindo may publish in the future.

Co-authorship network of co-authors of Keisuke Shindo

This figure shows the co-authorship network connecting the top 25 collaborators of Keisuke Shindo. A scholar is included among the top collaborators of Keisuke Shindo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keisuke Shindo. Keisuke Shindo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 13
3 4
4 10
5 25
6 12
7 9
8 43
9 31
10 31
11 16
12 20
13 86
14 44
15 102
16 185
17 65
18 43
19 152
20 26

About Keisuke Shindo

Keisuke Shindo is a scholar working on Virology, Infectious Diseases and Immunology, having authored 35 papers that have together received 1.8k indexed citations. Recurring topics across this work include HIV Research and Treatment (20 papers), HIV/AIDS drug development and treatment (16 papers) and Cytomegalovirus and herpesvirus research (8 papers). The work is most often cited by research in Virology (1.1k citations), Infectious Diseases (641 citations) and Immunology (459 citations). Keisuke Shindo has collaborated with scholars based in Japan, United States and Slovakia. Frequent co-authors include Reuben S. Harris, Akifumi Takaori‐Kondo, John S. Albin, Masayuki Kobayashi, William L. Brown, Hiroshi Matsuo, Eric W. Refsland, Mark D. Stenglein, Elena Harjes and Keiko Fukunaga. Their work appears in journals such as Nature, Nucleic Acids Research and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026